RMD vs. GILD
RMD (ResMed Inc.) and GILD (Gilead Sciences, Inc.) are both stocks. Both are in the Healthcare sector — RMD in Medical Instruments & Supplies, GILD in Drug Manufacturers - General. Over the past 10 years, RMD returned 13.71%/yr vs 8.00%/yr for GILD. At a 0.24 correlation, their price movements are largely independent.
Performance
RMD vs. GILD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RMD achieves a -19.39% return, which is significantly lower than GILD's 4.96% return. Over the past 10 years, RMD has outperformed GILD with an annualized return of 13.71%, while GILD has yielded a comparatively lower 8.00% annualized return.
RMD
- 1D
- -1.48%
- 1M
- -6.31%
- YTD
- -19.39%
- 6M
- -22.35%
- 1Y
- -22.67%
- 3Y*
- -2.34%
- 5Y*
- -0.97%
- 10Y*
- 13.71%
GILD
- 1D
- -0.82%
- 1M
- -2.46%
- YTD
- 4.96%
- 6M
- 7.00%
- 1Y
- 16.94%
- 3Y*
- 21.99%
- 5Y*
- 17.59%
- 10Y*
- 8.00%
RMD vs. GILD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RMD ResMed Inc. | -19.39% | 6.26% | 34.18% | -16.55% | -19.47% | 23.41% | 38.33% | 37.85% | 36.38% | 39.06% |
GILD Gilead Sciences, Inc. | 4.96% | 36.59% | 18.68% | -1.99% | 23.63% | 29.95% | -6.70% | 7.88% | -9.92% | 2.96% |
Correlation
The correlation between RMD and GILD is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Jun 2, 1995 | 0.24 |
Fundamentals
RMD:
$13.78
GILD:
$7.35
RMD:
14.02
GILD:
17.43
RMD:
0.43
GILD:
0.04
RMD:
3.85
GILD:
5.40
RMD:
$5.54B
GILD:
$29.74B
RMD:
$3.42B
GILD:
$18.74B
RMD:
$2.10B
GILD:
$12.88B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RMD vs. GILD — Risk / Return Rank
RMD
GILD
RMD vs. GILD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ResMed Inc. (RMD) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RMD | GILD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.60 | ||
| Sortino ratioReturn per unit of downside risk | -2.38 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 1.13 | -0.28 |
| Calmar ratioReturn relative to maximum drawdown | -0.61 | 0.96 | -1.57 |
| Martin ratioReturn relative to average drawdown | -1.42 | 2.35 | -3.78 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RMD | GILD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.95 | 0.65 | -1.60 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.03 | 0.74 | -0.77 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.44 | 0.32 | +0.12 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.52 | 0.38 | +0.13 |
Drawdowns
RMD vs. GILD - Drawdown Comparison
The maximum RMD drawdown since its inception was -61.61%, smaller than the maximum GILD drawdown of -70.83%. Use the drawdown chart below to compare losses from any high point for RMD and GILD.
Loading charts...
Drawdown Indicators
| RMD | GILD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.61% | -70.83% | +9.22% |
Max Drawdown (1Y)Largest decline over 1 year | -37.28% | -17.65% | -19.63% |
Max Drawdown (3Y)Largest decline over 3 years | -40.09% | -26.59% | -13.50% |
Max Drawdown (5Y)Largest decline over 5 years | -53.99% | -26.59% | -27.40% |
Max Drawdown (10Y)Largest decline over 10 years | -53.99% | -30.47% | -23.52% |
Current DrawdownCurrent decline from peak | -33.74% | -17.31% | -16.43% |
Average DrawdownAverage peak-to-trough decline | -15.98% | -22.16% | +6.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.95% | 7.22% | +8.73% |
Volatility
RMD vs. GILD - Volatility Comparison
ResMed Inc. (RMD) has a higher volatility of 10.44% compared to Gilead Sciences, Inc. (GILD) at 6.75%. This indicates that RMD's price experiences larger fluctuations and is considered to be riskier than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RMD | GILD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.44% | 6.75% | +3.69% |
Volatility (6M)Calculated over the trailing 6-month period | 19.50% | 18.45% | +1.05% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.97% | 26.29% | -2.32% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.12% | 24.03% | +7.09% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.55% | 25.49% | +6.06% |
Dividends
RMD vs. GILD - Dividend Comparison
RMD's dividend yield for the trailing twelve months is around 1.24%, less than GILD's 2.49% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 2.49% | 2.57% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% |
RMD ResMed Inc. | 1.24% | 0.94% | 0.88% | 1.07% | 0.83% | 0.62% | 0.73% | 0.98% | 1.26% | 1.61% | 2.03% | 2.16% |
Financials
RMD vs. GILD - Financials Comparison
This section allows you to compare key financial metrics between ResMed Inc. and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RMD vs. GILD - Profitability Comparison
RMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported a gross profit of 890.98M and revenue of 1.43B. Therefore, the gross margin over that period was 62.3%.
GILD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Gilead Sciences, Inc. reported a gross profit of 79.20M and revenue of 6.96B. Therefore, the gross margin over that period was 1.1%.
RMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported an operating income of 499.81M and revenue of 1.43B, resulting in an operating margin of 34.9%.
GILD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Gilead Sciences, Inc. reported an operating income of 2.59B and revenue of 6.96B, resulting in an operating margin of 37.2%.
RMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported a net income of 398.73M and revenue of 1.43B, resulting in a net margin of 27.9%.
GILD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Gilead Sciences, Inc. reported a net income of 2.02B and revenue of 6.96B, resulting in a net margin of 29.0%.
Frequently Asked Questions
RMD and GILD have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RMD has higher volatility (10.44%) compared to GILD (6.75%). In terms of maximum drawdown, RMD dropped -61.61% vs GILD's -70.83%.
GILD currently has the higher Sharpe Ratio (0.65 vs -0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RMD and GILD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer